Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melanoma Stage III or IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT02507076
What this trial is testing

Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma

Who this might be right for
Basal Cell Carcinoma of the SkinEccrine Carcinoma of the SkinRecurrent Adult Soft Tissue Sarcoma+8 more
Albert Einstein College of Medicine
Large-scale testing (Phase 3)Active Not RecruitingNCT05352672
What this trial is testing

Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma

Who this might be right for
Melanoma
Regeneron Pharmaceuticals 1,546
Testing effectiveness (Phase 2)Ended earlyNCT00184067
What this trial is testing

Continuation Booster Trial After a Vaccine Combining Tyrosinase/GP100/MART-1 Peptides Emulsified With Montanide ISA 51 With or Without GM-CSF for Patients With Melanoma

Who this might be right for
Melanoma
University of Southern California 23
Testing effectiveness (Phase 2)Ended earlyNCT03301636
What this trial is testing

Indoximod or Placebo Plus Pembrolizumab or Nivolumab for Subjects With Unresectable or Metastatic Melanoma

Who this might be right for
Melanoma
NewLink Genetics Corporation 21
Testing effectiveness (Phase 2)Study completedNCT04570332
What this trial is testing

BO-112 With Pembrolizumab in Unresectable Malignant Melanoma

Who this might be right for
Melanoma
Highlight Therapeutics 42
Early research (Phase 1)Study completedNCT00006368
What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60
Early research (Phase 1)Ended earlyNCT02097225
What this trial is testing

Onalespib, Dabrafenib, and Trametinib in Treating Patients With BRAF-Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
BRAF V600E Mutation PresentBRAF V600K Mutation PresentMetastatic Malignant Solid Neoplasm+7 more
National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Ended earlyNCT02587650
What this trial is testing

Capmatinib, Ceritinib, Regorafenib, or Entrectinib in Treating Patients With BRAF/NRAS Wild-Type Stage III-IV Melanoma

Who this might be right for
ALK Fusion Protein ExpressionBRAF wt AlleleInvasive Skin Melanoma+12 more
University of California, San Francisco 1
Early research (Phase 1)Study completedNCT01008527
What this trial is testing

Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100

Who this might be right for
Melanoma
H. Lee Moffitt Cancer Center and Research Institute 22
Early research (Phase 1)WithdrawnNCT00803374
What this trial is testing

Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb
Not applicableNo Longer AvailableNCT00495066
What this trial is testing

Compassionate Use Trial for Unresectable Melanoma With Ipilimumab

Who this might be right for
Melanoma
Bristol-Myers Squibb
Testing effectiveness (Phase 2)WithdrawnNCT02452281
What this trial is testing

Pilot Study to Evaluate the Effects of a Vaccine (HSPPC-96) Combined With Ipilimumab in Patients With Advanced Melanoma

Who this might be right for
Melanoma
Rabih Said
Early research (Phase 1)Study completedNCT00118313
What this trial is testing

Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Craig L Slingluff, Jr
Testing effectiveness (Phase 2)Looking for participantsNCT05136196
What this trial is testing

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+22 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00651703
What this trial is testing

Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma Patients

Who this might be right for
Malignant Melanoma
Cytos Biotechnology AG 21
Early research (Phase 1)Study completedNCT00790010
What this trial is testing

Bevacizumab Plus Ipilimumab in Patients With Unresectable Stage III or IV Melanoma

Who this might be right for
Melanoma
Dana-Farber Cancer Institute 46
Testing effectiveness (Phase 2)Ended earlyNCT02314143
What this trial is testing

Phase II Biomarker Study Comparing the Combination of BRAF Inhibitor Dabrafenib With MEK Inhibitor Trametinib Versus the Combination After Monotherapy With Dabrafenib or Trametinib

Who this might be right for
Melanoma
GlaxoSmithKline 48
Testing effectiveness (Phase 2)Ended earlyNCT01474551
What this trial is testing

Vemurafenib (R05185426) in Poor Performance Status Patients With Unresectable Locally Advanced or Metastatic Melanoma Harboring a V600E/K Mutation

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 2
Testing effectiveness (Phase 2)Study completedNCT00281541
What this trial is testing

The Treatment of Unresectable Stage III or Metastatic Stage IV Melanoma

Who this might be right for
Melanoma
Astellas Pharma Inc 29
Testing effectiveness (Phase 2)Study completedNCT00243594
What this trial is testing

Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection

Who this might be right for
Melanoma Stage III or IV
Radboud University Medical Center 40
Next Page
150